Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
498 hedge funds and large institutions have $13.9B invested in Abiomed Inc in 2020 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 165 increasing their positions, 189 reducing their positions, and 60 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
17% more capital invested
Capital invested by funds: $11.9B → $13.9B (+$2.02B)
8% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 60
0% more funds holding
Funds holding: 498 → 498 (0)
1% less call options, than puts
Call options by funds: $225M | Put options by funds: $227M
13% less repeat investments, than reductions
Existing positions increased: 165 | Existing positions reduced: 189
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$75.5M |
| 2 |
BlackRock
New York
|
+$50.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$40.4M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$26.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$21.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$72.8M |
| 2 |
Primecap Management
Pasadena,
California
|
-$48.7M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$45M |
| 4 |
Two Sigma Investments
New York
|
-$29.1M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$28.3M |
ABMD Hedge Fund Activity: Q4 2020 in Review
498 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2020, worth a combined $13.9B — up 17% from $11.9B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new ABMD positions and 60 closed out — a net gain of 5 holders — while 165 added to existing stakes and 189 trimmed.
The largest buyer was Invesco, adding an estimated $75.5M. The largest seller was Renaissance Technologies, cutting an estimated $72.8M.
- 498 institutional investors held Abiomed Inc (ABMD) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $13.9B of Abiomed Inc stock for Q4 2020, up 17% quarter-over-quarter.
- 65 funds opened new Abiomed Inc positions in Q4 2020 and 60 closed out, a net change of +5 holders.
- The largest Abiomed Inc buyer in Q4 2020 was Invesco, an estimated $75.5M added.
- The largest Abiomed Inc seller in Q4 2020 was Renaissance Technologies, an estimated $72.8M sold.
Based on aggregated 13F filings for Q4 2020.